我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

补肾益骨方联合阿仑膦酸钠对2型糖尿病并发骨质疏松患者疗效和骨密度的影响*(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2018年01期
页码:
54-56
栏目:
临床研究
出版日期:
2018-06-30

文章信息/Info

Title:
-
作者:
王春雷孙清林胥柯蒯凤黄飞刘艳梅
(盐城市第一人民医院,江苏 盐城 224005)
Author(s):
-
关键词:
补肾益骨方 2型糖尿病 骨质疏松 阿仑膦酸钠 骨密度
Keywords:
-
分类号:
R259
DOI:
10.19288/j.cnki.issn.1000-2723.2018.01.013
文献标识码:
A
摘要:
目的探讨补肾益骨方联合阿仑膦酸钠对2型糖尿病并发骨质疏松患者疗效和骨密度的影响。方法选择2型糖尿病并发骨质疏松症患者94例,随机分为观察组48例、对照组46例,2组均采用降糖药物或胰岛素控制血糖,对照组在此基础上给予阿仑膦酸钠,观察组在对照组基础上给予补肾益骨方,比较2组临床疗效、骨密度、血糖变化情况。结果观察组疗效明显优于对照组(P<0.05);治疗后2组骨密度明显升高(P<0.05),且观察组高于对照组(P<0.05);2组FPG、2hPG及HbA1c均降低(P<0.05),2组FPG、2hPG、HbA1c比较差异无统计学意义(P>0.05)。结论补肾益骨方可有效提高2型糖尿病骨质疏松患者骨密度,改善临床症状,同时不影响血糖控制。
Abstract:
-

参考文献/References

[1] 刘林,刘海峰. 阿仑膦酸钠与阿法骨化醇联合治疗老年2型糖尿病骨质疏松患者疗效及骨代谢分析[J]. 中国医学创新,2016,13(34):30-33.
[2] 王志全. 健骨丸治疗2型糖尿病性骨质疏松症肾虚型的临床疗效观察[D]. 南京:南京中医药大学,2017.
[3] RAZI F,ESMAILI M,ESFAHANI E N,et al. Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus[J]. Menopause,2016,23(3):280-285.
[4] 王双,李军,李思源,等. 骨钙素在2型糖尿病合并骨质疏松中意义的研究[J]. 中国骨质疏松杂志,2017,23(4):469-472.
[5] DYTFELD J,MICHALAK M. Type 2 diabetes and risk of low-energy fractures in postmenopausal women:meta-analysis of observational studies[J]. Aging Clin Exp Res,2017,29(2):301-309.
[6] 古丽努尔·伊斯拉木,李应琴. 2型糖尿病合并骨质疏松症患者血清C肽、骨钙素水平检测[J]. 广州医科大学学报,2014(4):35-37.
[7] VUJOSEVIC S,BOROZAN S,RADOJEVIC N,et al. Relationship between 25-hydroxyvitamin D and newly diagnosed type 2 diabetes mellitus in postmenopausal women with osteoporosis[J]. Med Princ Pract,2014,23(3):229-233.
[8] DE PERGOLA G,TRIGGIANI V,BARTOLOMEO N,et al. Independent relationship of osteocalcin circulating levels with obesity,type 2 diabetes,hypertension,and HDL cholesterol[J]. Endocr Metab Immune Disord Drug Targets,2016,16(4):270-275.
[9] 麻红艳,叶山东. 老年男性2型糖尿病患者骨质疏松相关因素分析[J]. 中华疾病控制杂志,2017,21(7):688-692.
[10] BILIC-CURCIC I,MAKAROVIC S,MIHALJEVIC I,et al. Bone mineral density in relation to metabolic syndrome components in postmenopausal women with diabetes mellitus type 2[J]. Acta Clin Croat,2017,56(1):58-63.
[11] 郭玉卿. 补肾壮骨汤联合阿托伐他汀治疗糖尿病性骨质疏松症临床疗效观察[J]. 糖尿病新世界,2017(24):74-75.
[12] BOTELLA MARTINEZ S,VARO CENARRUZABEITIA N,ESCALADA SAN MARTIN J,et al. The diabetic paradox:bone mineral density and fracture in type 2 diabetes[J]. Endocrinol Nutr,2016,63(9):495-501.
[13] ZHOU L,SONG J,YANG S,et al. Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet:a retrospective cross-sectional study[J]. Osteoporos Int,2017,28(5):1693-1698.
[14] 胡玲萍,吴雪华. 老年男性2型糖尿病并发骨质疏松相关危险因素研究现状[J]. 中国临床保健杂志,2014(1):107-109.
[15] DYTFELD J,MICHALAK M. Type 2 diabetes and risk of low-energy fractures in postmenopausal women:meta-analysis of observational studies[J]. Aging Clin Exp Res,2017,29(2):301-309.
[16] ZHUKOUSKAYA W,ELLER-VAINICHER C,GAUDIO A,et al. In postmenopausal female subjects with type 2 diabetes mellitus,vertebral fractures are independently associated with cortisol secretion and sensitivity[J]. J Clin Endocrinol Metab,2015,100(4):1417-1425.
[17] 陈基敏,陈咸川,谢吟灵. 阿仑膦酸钠对绝经后女性骨质疏松症患者动脉粥样硬化影响的研究[J]. 中国实验诊断学,2016,20(4):544-547.
[18] RASKA I J R,RASKOVA M,ZIKAN V,et al. Prevalence and risk factors of osteoporosis in postmenopausal women with type 2 diabetes mellitus[J]. Cent Eur J Public Health, 2017,25(1):3-10.
[19] BLEVINS T C,FAROOKI A. Bone effects of canagliflozin,a sodium glucose co-transporter 2 inhibitor,in patients with type 2 diabetes mellitus[J]. Postgrad Med,2017,129(1):159-168.
[20] 陈叶. 滋肾降糖丸防治糖尿病骨质疏松的临床及实验研究[D]. 广州:广州中医药大学,2016.

备注/Memo

备注/Memo:
基金项目: 盐城市科技计划项目(YK2016012) 收稿日期: 2018 - 02- 06 作者简介: 王春雷(1982-),男,医学硕士,主治医师,研究方向:骨代谢疾病的治疗。 △通信作者: 刘艳梅,E-mail:lym_jsyc@sina.com
更新日期/Last Update: 2018-06-30